Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Special Reports
Top 20 pharma companies by 2023 revenue
Novo Nordisk and Eli Lilly had huge revenue gains in 2023, while sellers of COVID products Pfizer, Moderna and BioNTech saw major sales declines.
Kevin Dunleavy
Apr 15, 2024 3:00am
Merck KGaA turns to storytelling for schistosomiasis awareness
Apr 2, 2024 11:37am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am
Merck KGaA's MilliporeSigma makes €300M pledge at new Korea site
Mar 21, 2024 1:22pm
Despite solid pharma growth, Merck KGaA sees total sales decline
Mar 7, 2024 3:32pm
With record year, Samsung Bio bucks CDMO industry's tough 2023
Jan 25, 2024 10:33am